Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer
Clinical trial NCT02833766 · TERMINATED
Trial details
- NCT number
- NCT02833766
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-28
- Primary completion
- 2020-10-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.